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Over the past few years, news of positive
drug tests, BALCO, and tarnished records
have led many people to wonder whether it
is possible to have sports without drugs. The
crux of this question is whether it is possible
to have muscle growth without the growth
factor and hormone drugs that all too many
athletes take.
Increases in muscle size have largely been
attributed to two factors: the mechanical
load and the growth factor environment
that the muscle experiences. However, the
relative contribution of each factor is
unknown. The difficulty in distinguishing
between the two factors is one of the
primary reasons that this question remains
unanswered after almost 40 years of study. In
the late 1960s, Goldberg conducted a series
of studies on the role of insulin and other
hormones on muscle growth (for review see
Goldberg et al. 1975). In this work, he clearly
showed that mechanical loading increased
both protein synthesis and amino acid
transport leading to muscle growth. Further,
he demonstrated that muscle hypertrophy
occurred in normal, diabetic, and hypo-
Figure 1. Schematic diagram of the
signalling pathway associated with
skeletal muscle hypertrophy
Insulin and growth factors (GF) signal
through the insulin receptor and its
substrate (IRS1), whereas resistance
exercise bypasses this receptor and
activates protein kinase B (PKB)/akt
independently of the insulin receptor. In
both cases, the mammalian target of
rapamycin (mTOR) is activated leading to
protein synthesis via the protooncogene
myc, the liberation of eukaryotic initiation
factor (eIF) 4E from its repressor the eIF4E
binding protein (4E-BP), and the activation
of the 70 kDa ribosomal S6 kinase (S6K1).
physectomized animals, suggesting that
neither insulin nor pituitary hormones
(primarily growth hormone) were required
for adult skeletal muscle hypertrophy. While
these experiments showed that systemic
insulin and growth hormone were not
required, they did not definitively rule
out a role for growth factors, as locally
produced growth factors may compensate
for the absence of systemic insulin or growth
hormone.
Even with the advent of more sophisticated
techniques, questions concerning the role
of growth factors in muscle hypertrophy
have persisted. Identification of a strong
correlation between the magnitude of the
load placed on a muscle, the activity
of the mammalian target of rapamycin
(mTOR), and muscle growth suggested
that the mechanical load was the primary
determinant of muscle growth (Baar & Esser,
1999). However, mTOR is also activated
by many growth factors such as insulin
and insulin-like growth factor 1 (IGF1) and
muscle cells produce and secrete growth
factors following mechanical loading that
can activate mTOR and induce muscle
growth in unstretched cells (Baar et al.
2000), suggesting that mechanical loading
results in the production of autocrine factors
that may play a role in the development of
muscle hypertrophy.
The finding that, in response to mechanical
loading, muscle produces both IGF1 and a
variant of IGF1 termed mechano-growth
factor (MGF) provided strong support for
this hypothesis (McKoy et al. 1999). Further,
overproduction of IGF1 in muscle results
in significant skeletal muscle hypertrophy
(Coleman et al. 1995) leading many to
hypothesize that mechanical loading
increases muscle mass largely by increasing
the autocrine production of IGF1 or an
IGF1 related growth factor (Adams &
Haddad, 1996).
In an elegant study in this issue of The
Journal of Physiology, Spangenburg et al.
(2008) directly test this hypothesis. By
virtue of their experimental design, the
authors were able to distinguish between
the effects of the mechanical load and
the growth factors where others haven’t
by using a mouse line with muscles that
cannot respond to either insulin or IGF1.
As a result, they could directly determine
the contribution of mechanical loading
independently of systemic and autocrine
growth factors. Since growth factors play
an important role in developmental growth,
the muscles of the transgenic mice were, as
expected, smaller than wild-type controls.
The surprise comes when the muscles
of these animals are challenged with an
increased load. Whereas the prevailing
hypothesis would predict a diminished
ability to grow, the muscles of the
transgenic mice grow and activate mTOR
to the same extent as wild-type controls.
The implication is that the activation
of mTOR and muscle growth is entirely
dictated by the mechanical load the muscle
experiences.
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If growth factors aren’t required for the
activation of mTOR or muscle growth,
how is the mechanical signal transduced
to a chemical signal that promotes
hypertrophy (Fig. 1)? One possibility is that
mechanical loading activates phospholipase
D resulting in the activation of mTOR
and muscle hypertrophy (Hornberger et al.
2006). However, this doesn’t explain the
activation of PKB/akt that occurs following
resistance exercise. Another possibility is
that mechanical loading overcomes the
requirement for the growth factor receptor
by altering the normal turnover of signalling
molecules at the membrane. In this way,
both PKB/akt and mTOR can be activated
in the absence of growth factors.
While growth factors and hormones are
important developmentally in determining
the size of our bodies, it is clear from
the work of Spangenburg et al. that the
primary stimulus for adult skeletal muscle
hypertrophy is the mechanical
environment. While this probably won’t
affect drug use among individuals seeking
supramaximal muscle growth, for those
of us that hold out hope, it suggests that
hard work can increase muscle mass in the
absence of external growth factors.
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